SBIR/STTR Research Award

Pan-HIV Incidence Assay Development

Award identifier 1b5843c89249e91a35b000e9b65c072c0b44d373bebd3356b7c8b2751ac15beaAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,707

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ImmPORT Therapeutics Inc dba Antigen Discovery Inc
Proposal award date
2018-08-16
Contract end date
2019-07-31
UEI
ZJAMPJY7M149
Solicitation number
PA16-302
Topic code
NIAID

Research abstract

PanHIV Incidence Assay DevelopmentAbstractHIVcontinues to cause the largest number of yearly deaths from a single infectious agent in the world todayDespiteconsiderableadvancesintreatmentofHIVinfectionandAIDSwhichitcausesthereisanurgentneed for better methods of prevention and treatment of HIVinfection and AIDSAs part of this effortthe WorldHealth OrganizationWHOand the Joint United Nations Program on HIV AIDSUNAIDSconduct worldwidesurveys of HIV infection incidenceprevalence and mortalityIncidence data are vitally needed by governmentsandnongovernmentalorganizationstobestdirecteffortsandlimitedresourcesaimedatpreventionofHIVtransmission and treatment of HIV infectionThe limiting antigen avidity enzyme immunoassayLag assayiscurrently widely used to test for HIV incidence but this assay only detects very recent infections and does notwork well for all subtypes of HIVAntigen Discovery IncADIof Irvine Californiahas created a panHIV proteomic microarraypanHIV chipthatcontainsallproteinsandmanyproteinfragmentsandepitopesfromnineHIVsubtypesandcirculatingrecombinant forms as well as both major groups of HIVwhich together comprise overof HIV infectionsworldwideWealsoaddedglycosylatedanddisulfideboundformsofHIVglycoproteinsandglycoproteinfragmentsresultinginatotalofoverimmunoreactiveHIVproteinsproteinsfragmentsandepitopesMoreoverwe assayed the reactivity of this HIV protein microarray with IgGIgA and IgM in a panel ofseraand saliva samplesobtained from the Consortium for the Evaluation and Performance of HIV Incidence AssaysCEPHIAthatcomprisetheHIVRecencyBiomarkerScreeningHRBSsetOurpreliminarydatashowthatcertain HIV antigensVifVpupTatRevEnv and Env fragments are much less strongly recognized by IgGin sera and saliva from recently infected individuals compared to those with longerterm infectionIn contrastEnvEnv fragmentsTatRevCA and PR are more strongly recognized by IgM in sera and saliva from recentlyinfected individuals compared to those with longerterm infectionBased on these extensive preliminary datawehypothesizethatwecandevelopahighlysensitiveandspecificHIVrecencyofinfectiontestingalgorithmRITAthat will be useful for individuals infected with all types and subtypes of HIVPanHIV Incidence Assay DevelopmentAbstractHIVcontinues to cause the largest number of yearly deaths from a single infectious agent in the world todayDataonhowmanynewinfectionsoccuryearlyarevitallyneededtobestdirecteffortsandlimitedresourcesaimed at prevention of HIV transmission and treatment of HIV infectionThe current test for new HIV infectionsis not optimalwe plan to develop a more comprehensive and specific test of recent HIV infection

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

25 SBIR/STTR records share this UEI (2004–2025). Reported award amounts total $16,715,675. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.